Red List

CRMDCorMedix Inc.

Healthcare · Biotechnology · small-cap ($577M)
-49.6%
from rolling 252-day high of $14.96 set 2025-08-29 · 352d ago
Current
$7.54
Decline depth
-49.6%
Decline σ
3.5σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$CRMD has been tracked since 2026-03-01. It was down 58.6% from its 52-week high then — now down -49.6%.

It has clawed back 1.9 percentage points off that level. It bottomed 64.1% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CRMD qualifies for the Red List on decline depth.

Decline depth
-49.6%
From rolling 252-day high of $14.96, 352d ago. Past the 40% Red List threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.5σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (4.79% per day).

The structural read

What price action says about CRMD.

CRMD qualifies for the Red List on decline depth — down -49.6% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Upstream TFC read: weak alignment, current phase weekly. Last bar types — daily 2D (red), weekly 3 (green), monthly 2D (red).

Earnings on file: 2026-05-14. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about CRMD

What people ask.

Why is CRMD on Broken Stocks?

CRMD qualifies for the Red List on decline depth. It is down -49.6% from its rolling 252-day high of $14.96, set on 2025-08-29 — 352d ago.

Is CRMD a falling knife?

Not by the strict technical definition. CRMD is down -49.6% from its 52-week high, but that high was set 352d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. CRMD is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is CRMD a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CRMD trading inside its 52-week range?

At $7.54, CRMD sits 16.0% of the way from its 52-week low ($6.13) to its 52-week high ($14.96). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CRMD been declining?

The current 49.6% decline accrued over 352d, which annualizes to roughly -51.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CRMD compare to its sector?

There are 145 other Healthcare tickers on Broken Stocks: 68 Red, 40 Amber, 37 Watch, with 57 showing recovering structural signals. Median sector decline is -35.7% — CRMD's decline is deeper than the sector median.

Does CRMD's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-14) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.